NFE2L2 and cancer: This and other targeted approaches, together with direct NRF2 inhibitors such as natural and small-molecular NRF2 inhibitors [37,52], might constitute a promising strategy against the chemoresistance mechanisms of cancer and an improved efficacy of standard therapies.